Aprepitant as an antipruritic agent?
Arnaud
A
Duval
Louis
L
Dubertret
D000932:Antiemetics / Q000627:therapeutic use; D000077608:Aprepitant; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D064729:Neurokinin-1 Receptor Antagonists; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology; D012751:Sezary Syndrome / Q000150:complications*; D012878:Skin Neoplasms / Q000150:complications*
D000932:Antiemetics; D009025:Morpholines; D064729:Neurokinin-1 Receptor Antagonists; D000077608:Aprepitant